[go: up one dir, main page]

DE69928270D1 - Neutraler aminosäurentransporter und korrespondierendes gen - Google Patents

Neutraler aminosäurentransporter und korrespondierendes gen

Info

Publication number
DE69928270D1
DE69928270D1 DE69928270T DE69928270T DE69928270D1 DE 69928270 D1 DE69928270 D1 DE 69928270D1 DE 69928270 T DE69928270 T DE 69928270T DE 69928270 T DE69928270 T DE 69928270T DE 69928270 D1 DE69928270 D1 DE 69928270D1
Authority
DE
Germany
Prior art keywords
amino acid
neutral amino
acid transport
corresponding gen
gen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69928270T
Other languages
English (en)
Other versions
DE69928270T2 (de
Inventor
Hitoshi Endou
Yoshikatsu Kanai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
J Pharma Co Ltd
Original Assignee
Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Publication of DE69928270D1 publication Critical patent/DE69928270D1/de
Application granted granted Critical
Publication of DE69928270T2 publication Critical patent/DE69928270T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69928270T 1998-09-03 1999-09-03 Neutraler aminosäurentransporter und korrespondierendes gen Expired - Lifetime DE69928270T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP24999398 1998-09-03
JP24999398 1998-09-03
JP24854699A JP4689781B2 (ja) 1998-09-03 1999-09-02 アミノ酸輸送蛋白及びその遺伝子
JP24854699 1999-09-02
PCT/JP1999/004789 WO2000014228A1 (fr) 1998-09-03 1999-09-03 Transporteur d'acides amines neutres et gene correspondant

Publications (2)

Publication Number Publication Date
DE69928270D1 true DE69928270D1 (de) 2005-12-15
DE69928270T2 DE69928270T2 (de) 2006-08-03

Family

ID=26538829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928270T Expired - Lifetime DE69928270T2 (de) 1998-09-03 1999-09-03 Neutraler aminosäurentransporter und korrespondierendes gen

Country Status (7)

Country Link
US (6) US7332572B1 (de)
EP (1) EP1111048B1 (de)
JP (1) JP4689781B2 (de)
AU (1) AU766306B2 (de)
CA (1) CA2341777C (de)
DE (1) DE69928270T2 (de)
WO (1) WO2000014228A1 (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4750222B2 (ja) * 1998-09-03 2011-08-17 独立行政法人科学技術振興機構 アミノ酸輸送蛋白及びその遺伝子
JP4689781B2 (ja) * 1998-09-03 2011-05-25 独立行政法人科学技術振興機構 アミノ酸輸送蛋白及びその遺伝子
GB0024444D0 (en) * 2000-10-05 2000-11-22 Glaxo Group Ltd Novel protein
CA2449482A1 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. Chds as modifiers of the p53 pathway and methods of use
EP2000148A1 (de) 2001-06-20 2008-12-10 Genentech, Inc. Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Prostatakarzinom
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7803915B2 (en) * 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
EP1439228B1 (de) * 2001-09-28 2010-05-05 J-Pharma Co., Ltd. Neutrale aminosäure von geringer grösse transportierender natriumunabhängiger transporter, dessen gen und verfahren zur analyse der transporterfunktion mittels konstruktion von die spezifizierung der funktion ermöglichenden fusionsproteinen
JP4278906B2 (ja) 2002-02-18 2009-06-17 ジェイファーマ株式会社 酸性アミノ酸を輸送するナトリウム非依存性トランスポーター及びその遺伝子
CA2493870C (en) * 2002-03-13 2010-07-20 Creighton University Device and method for detecting antibiotic inactivating enzymes
CA2469992A1 (en) * 2003-06-06 2004-12-06 F. Hoffmann-La Roche Ag Transgenic animal model for glyt1 function
EP1483962A3 (de) * 2003-06-06 2005-01-12 F. Hoffmann-La Roche Ag Transgenes Tiermodel für Glyt1 Funktion
AU2004316290C1 (en) 2003-11-06 2012-02-02 Seagen Inc. Monomethylvaline compounds capable of conjugation to ligands
US7462459B2 (en) * 2004-01-30 2008-12-09 Xenoport, Inc. LAT1 transporters expressed in blood brain barrier cells
JP4560314B2 (ja) * 2004-03-17 2010-10-13 ジェイファーマ株式会社 中性アミノ酸トランスポーターによる癌の検出法、及びそのためのキット
JP5234734B2 (ja) 2004-06-01 2013-07-10 ジェネンテック， インコーポレイテッド 抗体−薬物結合体および方法
US20060003920A1 (en) * 2004-06-04 2006-01-05 Xenoport, Inc. LAT1 transporters expressed in cancer cells
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
WO2007084715A2 (en) * 2006-01-19 2007-07-26 Caprion Pharmaceuticals, Inc. Tat-031 and methods of assessing and treating cancer
TWI390034B (zh) 2006-04-06 2013-03-21 Kyowa Hakko Kirin Co Ltd Novel anti-CD98 antibody
CN105372425A (zh) * 2007-02-06 2016-03-02 J制药股份有限公司 前列腺癌的恶性程度判定试剂盒和其方法
EP2977761A1 (de) 2007-02-06 2016-01-27 J-Pharma Co., Ltd. Antikörper zum nachweis von prostatakrebsmalignität
WO2008108994A1 (en) * 2007-03-01 2008-09-12 Carnegie Institution Of Washington Trp/his exchange and kynurenine induced trp transport
EP2303332B1 (de) 2008-07-15 2014-12-31 Genentech, Inc. Anthracyclinkonjugate, verfahren zu deren herstellung und deren verwendung als antitumormittel
WO2011017049A1 (en) * 2009-07-27 2011-02-10 Cardiac Pacemakers, Inc. Medical device for treating heart failure through blood volume redistribution
JP2013504585A (ja) 2009-09-09 2013-02-07 セントローズ， エルエルシー 細胞外標的化薬物複合体
US20130052197A1 (en) 2010-03-26 2013-02-28 The University Of Tokushima Novel anti-cd98 antibody and use thereof
US9021394B2 (en) * 2010-04-01 2015-04-28 Eventsq Llc Capturing user feedback of software content in a networked environment and controlling the software using a single action
EA024730B1 (ru) 2010-04-15 2016-10-31 Медимьюн Лимитед Пирролбензодиазепиновые соединения, их конъюгаты, фармацевтические композиции, содержащие указанные конъюгаты, и применение указанных конъюгатов
CN107335062B (zh) 2010-06-08 2021-09-24 基因泰克公司 半胱氨酸改造的抗体和偶联物
JP5866138B2 (ja) * 2010-10-28 2016-02-17 幸雄 米田 骨粗鬆症の予防及び／又は治療剤、骨吸収抑制剤、骨形成促進剤及びそれらのスクリーニング方法
JP5889912B2 (ja) 2010-11-17 2016-03-22 ジェネンテック， インコーポレイテッド アラニニルメイタンシノール抗体コンジュゲート
ES2656988T3 (es) 2011-04-15 2018-03-01 J-Pharma Co., Ltd. Biomarcador para el cáncer de mama
EP2707723B1 (de) 2011-05-12 2016-02-10 Genentech, Inc. Lc-ms/ms-verfahren mit mehrfachreaktionsüberwachung zur erkennung therapeutischer antikörper in tierischen proben mittels rahmensignaturpeptiden
BR112014009050B1 (pt) 2011-10-14 2022-06-21 Medimmune Limited Conjugado anticorpo-fármaco de pirrolbenzodiazepinas, composição farmacêutica que compreende o mesmo, bem como compostos de pirrolbenzodiazepinas
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
WO2014057120A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
US10736903B2 (en) 2012-10-12 2020-08-11 Medimmune Limited Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
EP2766048B1 (de) 2012-10-12 2014-12-10 Spirogen Sàrl Pyrrolobenzodiazepine und konjugate davon
JP6392763B2 (ja) 2012-10-12 2018-09-19 エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ ピロロベンゾジアゼピン−抗体結合体
CA2887894C (en) 2012-10-12 2019-10-29 Adc Therapeutics Sarl Pyrrolobenzodiazepine - anti-psma antibody conjugates
CA2887899C (en) 2012-10-12 2020-03-31 Adc Therapeutics Sarl Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
CN105102068B (zh) 2012-10-12 2018-06-01 Adc疗法责任有限公司 吡咯并苯并二氮杂卓-抗体结合物
JP2013063978A (ja) * 2012-10-24 2013-04-11 J-Pharma Co Ltd 抗ヒトｌａｔ１モノクローナル抗体及び前立腺がんの悪性度判定キット
CN105189507A (zh) 2012-12-21 2015-12-23 斯皮罗根有限公司 吡咯并苯并二氮杂卓及其结合物
AU2013366490B9 (en) 2012-12-21 2018-02-01 Medimmune Limited Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
US20160031887A1 (en) 2013-03-13 2016-02-04 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
US9649390B2 (en) 2013-03-13 2017-05-16 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
CA2901941C (en) 2013-03-13 2020-04-07 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
CA2918139A1 (en) 2013-08-12 2015-02-19 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
EP3054983B1 (de) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
MX2016007578A (es) 2013-12-16 2016-10-03 Genentech Inc Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo [e] indol, y metodos de uso y tratamiento.
RU2689388C1 (ru) 2013-12-16 2019-05-28 Дженентек, Инк. Пептидомиметические соединения и их конъюгаты антител с лекарственными средствами
SG11201604905WA (en) 2013-12-16 2016-07-28 Genentech Inc Peptidomimetic compounds and antibody-drug conjugates thereof
US10188746B2 (en) 2014-09-10 2019-01-29 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
JP6622293B2 (ja) 2014-09-12 2019-12-18 ジェネンテック， インコーポレイテッド アントラサイクリンジスルフィド中間体、抗体−薬物複合体、及び方法
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
RU2017107502A (ru) 2014-09-12 2018-10-12 Дженентек, Инк. Антитела и конъюгаты, сконструированные введением цистеина
SG11201702079UA (en) 2014-09-17 2017-04-27 Genentech Inc Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
WO2016083468A1 (en) 2014-11-25 2016-06-02 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
AU2015358532C1 (en) 2014-12-03 2020-10-29 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
JP2015134778A (ja) * 2015-02-06 2015-07-27 ジェイファーマ株式会社 抗ヒトｌａｔ１モノクローナル抗体及び前立腺がんの悪性度判定キット
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
MA43345A (fr) 2015-10-02 2018-08-08 Hoffmann La Roche Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
MA43354A (fr) 2015-10-16 2018-08-22 Genentech Inc Conjugués médicamenteux à pont disulfure encombré
MA45326A (fr) 2015-10-20 2018-08-29 Genentech Inc Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
US20170315132A1 (en) 2016-03-25 2017-11-02 Genentech, Inc. Multiplexed total antibody and antibody-conjugated drug quantification assay
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
EP3458101B1 (de) 2016-05-20 2020-12-30 H. Hoffnabb-La Roche Ag Protac-antikörper-konjugate und verfahren zur verwendung
JP7022080B2 (ja) 2016-05-27 2022-02-17 ジェネンテック， インコーポレイテッド 部位特異的抗体－薬物複合体の特徴付けのための生化学分析的方法
WO2017214024A1 (en) 2016-06-06 2017-12-14 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
JP7093767B2 (ja) 2016-08-11 2022-06-30 ジェネンテック， インコーポレイテッド ピロロベンゾジアゼピンプロドラッグ及びその抗体コンジュゲート
EP3522933B1 (de) 2016-10-05 2021-12-15 F. Hoffmann-La Roche AG Verfahren zur herstellung von antikörperarzneimittelkonjugaten
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
HUE054689T2 (hu) 2017-02-08 2021-09-28 Adc Therapeutics Sa Pirrolobenzodiazepin-antitest konjugátumok
WO2018192944A1 (en) 2017-04-18 2018-10-25 Medimmune Limited Pyrrolobenzodiazepine conjugates
KR20190141666A (ko) 2017-04-20 2019-12-24 에이디씨 테라퓨틱스 에스에이 항-axl 항체-약물 접합체로의 병용 요법
WO2018229222A1 (en) 2017-06-14 2018-12-20 Adc Therapeutics Sa Dosage regimes for the administration of an anti-cd19 adc
SI3668874T1 (sl) 2017-08-18 2022-04-29 Medimmune Limited Pirolobenzodiazepinski konjugati
KR20220156974A (ko) 2017-09-20 2022-11-28 주식회사 피에이치파마 타일란스타틴 유사체
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
GB201814281D0 (en) 2018-09-03 2018-10-17 Femtogenix Ltd Cytotoxic agents
CN113056287A (zh) 2018-10-24 2021-06-29 豪夫迈·罗氏有限公司 缀合的化学降解诱导剂及使用方法
WO2020123275A1 (en) 2018-12-10 2020-06-18 Genentech, Inc. Photocrosslinking peptides for site specific conjugation to fc-containing proteins
GB201901197D0 (en) 2019-01-29 2019-03-20 Femtogenix Ltd G-A Crosslinking cytotoxic agents
MX2021010477A (es) 2019-03-15 2021-10-01 Medimmune Ltd Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
GB2597532A (en) 2020-07-28 2022-02-02 Femtogenix Ltd Cytotoxic compounds
EP4426727A2 (de) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Spezifische konjugation eines antikörpers
TW202432187A (zh) 2022-12-23 2024-08-16 美商建南德克公司 小腦蛋白降解劑結合物及其用途
WO2024220546A2 (en) 2023-04-17 2024-10-24 Peak Bio, Inc. Antibodies and antibody-drug conjugates and methods of use and synthetic processes and intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
JPH04157192A (ja) * 1990-10-19 1992-05-29 Fuji Photo Film Co Ltd 銀回収装置
US5695751A (en) * 1993-04-08 1997-12-09 Cornell Research Foundation, Inc. Enhancing delivery of large neutral amino acid drugs
EP0773288A3 (de) * 1995-08-29 1997-07-09 Kirin Brewery Chimäre-Tier und dessen Verfahren zur Herstellung
US5843727A (en) * 1997-04-08 1998-12-01 Incyte Pharmacuticals, Inc. Polynucleotides encoding a human tumor-associated membrane protein
JP4689781B2 (ja) * 1998-09-03 2011-05-25 独立行政法人科学技術振興機構 アミノ酸輸送蛋白及びその遺伝子

Also Published As

Publication number Publication date
US20120083588A1 (en) 2012-04-05
CA2341777C (en) 2013-01-08
US20050003490A1 (en) 2005-01-06
DE69928270T2 (de) 2006-08-03
AU5448799A (en) 2000-03-27
US20050019812A1 (en) 2005-01-27
US7335482B2 (en) 2008-02-26
WO2000014228A1 (fr) 2000-03-16
EP1111048A4 (de) 2001-11-21
EP1111048A2 (de) 2001-06-27
JP4689781B2 (ja) 2011-05-25
JP2000157286A (ja) 2000-06-13
US20050064475A1 (en) 2005-03-24
AU766306B2 (en) 2003-10-16
US20050019811A1 (en) 2005-01-27
EP1111048B1 (de) 2005-11-09
CA2341777A1 (en) 2000-03-16
US7666999B2 (en) 2010-02-23
US7332572B1 (en) 2008-02-19
US7413895B2 (en) 2008-08-19
US7332293B2 (en) 2008-02-19
WO2000014228A8 (fr) 2000-05-25

Similar Documents

Publication Publication Date Title
DE69928270D1 (de) Neutraler aminosäurentransporter und korrespondierendes gen
DE69832228D1 (de) Symmetrierschaltung
DK1089726T3 (da) Præparat omfattende beta-hydroxy-beta-methylsmørsyre og mindst en aminosyre
EE200000337A (et) Kombineeritud GPS- ja laiaribalise raadiotelefoni terminalid ja meetodid
NO982097D0 (no) Peptider
ATE220304T1 (de) Servier- und transportaufnahme
NO982098L (no) Peptider
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
DE59910730D1 (de) Von hand bewegbarer transportwagen
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ZA994406B (en) Meta-azacyclic amino benzoic acid and derivatives thereof.
DE69826837D1 (de) Inspektionsverfahren
ATE214870T1 (de) Sojabohnen mit reduziertem linolensauregerat
DE59802359D1 (de) Transportsystem
DE69918365D1 (de) Steckverbindungspaar und Steckverbindersatz
DE59808260D1 (de) Transporteinrichtung
DE59804343D1 (de) Schraubwerkzeug
DE69833414D1 (de) Modulator und Demodulator
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
DE69724381D1 (de) Nichtreziproke Schaltungsanordnung
GB9930519D0 (en) Uses of transport proteins
DE59804313D1 (de) Transportsystem
DE69842206D1 (de) Echounterdrücker und echounterdrückungsverfahren
DE69925271D1 (de) Angiostatin-bindendes protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: J-PHARMA CO.,LTD., TOKYO, JP